2008 AKORN MBOS: ART PRZYBYL PRESIDENT & CEO

EX-10.1 2 c26063exv10w1.htm 2008 MANAGEMENT BONUS OBJECTIVES exv10w1
 

Exhibit 10.1
*Confidential Treatment Requested Under
17 C.F.R. §§ 200.80(b)(4) and 240.24b-2
2008 AKORN MBO’S: ART PRZYBYL
PRESIDENT & CEO
Up to $330,000 (75% of Base Comp)
             
    Objective   Target   Percentage of Possible Bonus
     
1.
  [***...***]   [***...***]   [***...***]
2.
  [***...***]   [***...***]   [***...***]
3.
  [***...***]   [***...***]   [***...***]
4.
  [***...***]       [***...***]
5.
  [***...***]       [***...***]
6.
  [***...***]       [***...***]
7.
  [***...***]       [***...***]
 
*   CONFIDENTIAL TREATMENT REQUESTED — This language has been omitted and filed separately with the Securities and Exchange Commission.

 

 

*Confidential Treatment Requested Under
17 C.F.R. §§ 200.80(b)(4) and 240.24b-2
2008 AKORN MBO’S: JEFF WHITNELL
SVP FINANCE & CFO
Up to $123,750 (45% of Base Comp)
             
    Objective   Target   Percentage of Possible Bonus
     
1.
  [***...***]   [***...***]   [***...***]
2.
  [***...***]   [***...***]   [***...***]
3.
  [***...***]   [***...***]   [***...***]
4.
  [***...***]       [***...***]
5
  [***...***]       [***...***]
6
  [***...***]       [***...***]
7.
  [***...***]       [***...***]
 
*   CONFIDENTIAL TREATMENT REQUESTED — This language has been omitted and filed separately with the Securities and Exchange Commission.

 

 

*Confidential Treatment Requested Under
17 C.F.R. §§ 200.80(b)(4) and 240.24b-2
2008 AKORN MBO’S: ABU ALAM,
SVP NEW BUSINESS DEVELOPMENT
Up to $64,103 (30% of Base Comp)
             
    Objective   Target   Percentage of Possible Bonus
     
1.
  [***...***]   [***...***]   [***...***]
2.
  [***...***]   [***...***]   [***...***]
3.
  [***...***]   [***...***]   [***...***]
4.
  [***...***]       [***...***]
5.
  [***...***]       [***...***]
6.
  [***...***]       [***...***]
7.
  [***...***]       [***...***]
 
*   CONFIDENTIAL TREATMENT REQUESTED — This language has been omitted and filed separately with the Securities and Exchange Commission.

 

 

*Confidential Treatment Requested Under
17 C.F.R. §§ 200.80(b)(4) and 240.24b-2
2008 AKORN MBO’S: MARK SILVERBERG
SVP GLOBAL QUALITY ASSURANCE & REGULATORY COMPLIANCE
Up to $70,950 (30% of Base Comp)
             
    Objective   Target   Percentage of Possible Bonus
     
1.
  [***...***]   [***...***]   [***...***]
2.
  [***...***]   [***...***]   [***...***]
3.
  [***...***]   [***...***]   [***...***]
4.
  [***...***]       [***...***]
5.
  [***...***]       [***...***]
6.
  [***...***]       [***...***]
7.
  [***...***]       [***...***]
 
  [***...***]       [***...***]
 
*   CONFIDENTIAL TREATMENT REQUESTED — This language has been omitted and filed separately with the Securities and Exchange Commission.

 

 

*Confidential Treatment Requested Under
17 C.F.R. §§ 200.80(b)(4) and 240.24b-2
2008 AKORN MBO’S: JOHN SABAT
SVP NATIONAL ACCOUNTS & TRADE RELATIONS
Up to $64,103 (30% of Base Comp)
             
    Objective   Target   Percentage of Possible Bonus
     
1.
  [***...***]   [***...***]   [***...***]
2.
  [***...***]   [***...***]   [***...***]
3.
  [***...***]   [***...***]   [***...***]
4.
  [***...***]       [***...***]
5.
  [***...***]       [***...***]
6.
  [***...***]       [***...***]
7.
  [***...***]       [***...***]
 
*   CONFIDENTIAL TREATMENT REQUESTED — This language has been omitted and filed separately with the Securities and Exchange Commission.